StockData
BioNTech SE logo

BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$83.26−1.60 (-1.89%)

Close on Nov 18, 2026Market cap $20.92BP/E –Yield –

BioNTech gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was €2.23B, up 0.8% from the year before. The highest annual figure on record is €16.07B in fiscal 2021.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025€2.23B+0.8%
FY2024Dec 31, 2024€2.21B-31.4%
FY2023Dec 31, 2023€3.22B-77.5%
FY2022Dec 31, 2022€14.32B-10.9%
FY2021Dec 31, 2021€16.07B+3697.9%
FY2020Dec 31, 2020€423.00M+363.7%
FY2019Dec 31, 2019€91.23M-19.9%
FY2018Dec 31, 2018€113.89M+117.8%
FY2017Dec 31, 2017€52.28M–

More BioNTech figures

See a number that looks wrong?